Americans have become much more concerned about health care in recent months, with 18% naming it as the most important problem facing the U.S., according to a new Gallup survey. Mentions of health care were tied with mentions of “dissatisfaction with government/poor leadership” at the top of the survey’s “most important problems” list.
A revised version of the American Health Care Act (AHCA)––the GOP’s plan to repeal and replace the Obama administration’s Patient Protection and Affordable Care Act (PPACA)––is now being considered in the Senate, where further changes are expected.
Mark Bertolini, the CEO of Aetna, said in a Q&A with the insurer’s employees that he thinks that there should be a national discussion about the feasibility of turning health care into a single-payer system, according to Vox.
Galcanezumab (Eli Lilly), an investigational treatment for the prevention of episodic and chronic migraine, has met the primary endpoint in three phase 3 trials (EVOLVE-1, EVOLVE-2, and REGAIN), demonstrating statistically significant reductions in the number of monthly migraine headache days compared with placebo at both studied doses.
Between 2010 and 2015, the number of new hepatitis C virus (HCV) infections reported to the Centers for Disease Control and Prevention (CDC) nearly tripled, reaching a 15-year high, according to new surveillance data released by the agency.
The medical community is growing alarmed about a creeping malady that can diminish the quality of life for cancer patients and even shorten their lives, according to Yousuf Zafar, MD, MHS, a medical oncologist at Duke University. It’s found everywhere in the United States, but not to the same degree in other developed countries.
Leaders for Today (LFT), a national health care staffing company based in Wellesley, Massachusetts, conducted a survey of 852 health care candidates to better understand the job motivations, actions, and plans of people in the health care industry.
In the 1980s (or thereabouts) this expression became part of the zeitgeist: He who dies with the most stuff wins. Times have changed and many reading this have made plans for how they’d like to exit this world. Now, life’s winners are those who die quick.
The FDA has given the nod to pembrolizumab (Keytruda, Merck), an anti-programmed death 1 (PD-1) therapy, in combination with pemetrexed (Alimta, Eli Lilly) and carboplatin (pem/carbo), a commonly used chemotherapy regimen, for the first-line treatment of patients with metastatic nonsquamous non–small-cell lung cancer (NSCLC), irrespective of programmed de
Male primary care physicians earn 17% more than their female counterparts, while men in specialty care are paid 37% more than women in the same field, according to a new provider compensation report from the Medical Group Management Association. The report includes compensation data from 121,000 providers in the medical practice industry.